Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Tianshi Lyu"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The combination therapy of Tislelizumab plus Lenvatinib has recently emerged as the new standard of care for unresectable hepatocellular carcinoma (HCC). This treatment has demonstrated a significant reduction in tumor burden, raising the possibility
Externí odkaz:
https://doaj.org/article/42a23850acb84c20bb56165cb87950d8
Publikováno v:
Asian Journal of Surgery, Vol 47, Iss 8, Pp 3701-3702 (2024)
Externí odkaz:
https://doaj.org/article/bed1aab6fafe481991fbf515b07f2c97
Autor:
Yong Xie, Tianshi Lyu, Haitao Guan, Shoujin Cao, Li Song, Xiaoqiang Tong, Yinghua Zou, Jian Wang
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Background/objectiveThe aim of this study was to evaluate tumor progression and recurrence patterns of radiofrequency ablation (RFA) with or without transarterial chemoembolization (TACE) for treating hepatocellular carcinoma (HCC) that meets Milan c
Externí odkaz:
https://doaj.org/article/44867597eaee41cc8ae77de8c1bccc01
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Background/ObjectiveTreatment of hepatocellular carcinoma (HCC) with ablation alone often results in high rates of recurrence and metastasis, reaching up to 25.9% within two years. Therefore, this study aimed to examine the efficacy and safety of tra
Externí odkaz:
https://doaj.org/article/5ecb6266d7a54433b785d015ae9a2b73
Autor:
Shoujin Cao, Yinghua Zou, Tianshi Lyu, Zeyang Fan, Haitao Guan, Li Song, Xiaoqiang Tong, Jian Wang
Publikováno v:
International Journal of Hyperthermia, Vol 39, Iss 1, Pp 1-7 (2022)
Purpose To compare the long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation (TACE-RFA) with radiofrequency ablation (RFA) monotherapy for small (≤3 cm) hepatocellular carcinomas (HCCs). Methods A total of 248 p
Externí odkaz:
https://doaj.org/article/609a8eacfc8f45b4ac63c3a4b1e4d007
Autor:
Shoujin Cao, Tianshi Lyu, Zeyang Fan, Haitao Guan, Li Song, Xiaoqiang Tong, Jian Wang, Yinghua Zou
Publikováno v:
Cancer Imaging, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background/aim Recent studies have suggested that periportal location of percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is considered as one of the independent risk factors for local tumor progression (LTP). Ho
Externí odkaz:
https://doaj.org/article/3f9c4bd86b04462ab01fadc8011e3ffd
Publikováno v:
Journal of Interventional Medicine, Vol 3, Iss 2, Pp 61-64 (2020)
Since December 2019, coronavirus disease (COVID-19) has spread rapidly from Wuhan, Hubei province, to other regions of China. To reduce and prevent cross-over infections in the interventional diagnosis and treatment of tumor patients. The Interventio
Externí odkaz:
https://doaj.org/article/a36127382d3443df91e87b6a36e7ba8f
Publikováno v:
Journal of International Medical Research, Vol 47 (2019)
Objective To compare the outcomes of cone beam computed tomography (CBCT)-guided radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) with those of traditional spiral computed tomography (s-CT)-guided RFA. Methods This retrospective study
Externí odkaz:
https://doaj.org/article/184f24d87b394a11ba95f6ab1c048be7
Autor:
Tianshi Lyu1, Jian Wang1, Xiaoqiang Tong1, Tianai Mi2, Chao An2, Yinghua Zou1 yinghuazouu@163.com
Publikováno v:
Journal of Cancer Research & Therapeutics. Aug2023, Vol. 19 Issue 4, p933-938. 6p.
Publikováno v:
Indian Journal of Surgery. 85:254-258
Catheter rupture or displacement is a serious and rare complication of central venous catheterization, with an incidence of approximately 1%. Once the intravascular foreign body is found, it should be removed as soon as possible. This study investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e7ba2eac498c515186b0096e19fbe06
https://doi.org/10.1007/s12262-022-03395-3
https://doi.org/10.1007/s12262-022-03395-3